Actuate Therapeutics Share Price

NASDAQ: ACTU

Small Cap

$7.12

+0.08

(+1.21%)

Live

as on September 17, 2025 at 11:40 pm IST

$₹

Actuate Therapeutics Stock Performance

as on September 17, 2025 at 11:40 pm IST

Day's Low
Day's High
$6.92
Day's Price Range
$7.17
$7.12
2.81%
Downside
0.70%
Upside
52 Week's Low
52 Week's High
$5.47
52-Week Price Range
$11.99
$7.12
23.17%
Downside
68.40%
Upside

Actuate Therapeutics share price movements today

Previous Close: $7.04
Open: $7.05
Volume: 144.1K
Day's Low - High: $6.92 - $7.17
52 Week Low - High: $5.47 - $11.99

Actuate Therapeutics Historical Returns

1 Month Return: -13.3 %
3 Month Return: -9.4 %
1 Year Return: -12.22 %
3 Year Return: 0 %
5 Year Return: 0 %

Actuate Therapeutics Stock Fundamentals & Key Indicators

Check Actuate Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$162.7M

EPS (TTM)

-1.155

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

0.00%

Actuate Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Actuate Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Actuate Therapeutics	NA	$162.7M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Actuate Therapeutics Stock including INR - Dollar returns

The Actuate Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Actuate Therapeutics investment value today

Current value as on today

₹93,376

Returns

₹6,624

(-6.62%)

Returns from Actuate Therapeutics Stock

₹11,222 (-11.22%)

Dollar Returns*

₹4,598 (+4.6%)

Actuate Therapeutics Stock's Interest Amongst Investors

Search interest for Actuate Therapeutics Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:-11% versus previous 30 day period

Actuate Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-5	-5	-6	-7	-7	-5	-5	-6	-6	-5
EBITDA	-	-	-6	-7	-8	-6	-5	-6	-6	-5
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-5	-5	-6	-7	-8	-6	-5	-6	-6	-5
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-5	-5	-6	-7	-8	-6	-5	-6	-6	-5
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Actuate Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-
Gross Profit	-	-	-
Operating Income	-20	-24	-25
EBITDA	-20	-24	-25
Interest Expense	0	0	0
Depreciation	-	-	-
Income Before Tax	-20	-24	-27
Income Tax Expense	-	-	0
Net Income	-20	-24	-27
Net Profit Margin	0.00%	0.00%	0.00%

Actuate Therapeutics Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-5	-6	-7	-8	-6	-5	-6	-6	-5
Operating Cash Flow	-5	-5	-5	-5	-2	-9	-4	-4	-4
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	1	-	-	4	0	22	0	0	6
Change in Cash	-3	-5	-5	0	-1	13	-4	-4	2

Actuate Therapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2023	Dec 2024
Net Income	-24	-27
Operating Cash Flow	-21	-21
Investing Cash Flow	-	-
Financing Cash Flow	4	27
Change in Cash	-17	5

Insights on Actuate Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 80.3%
NEGATIVE IMPACT
Price Dip
In the last 1 month, ACTU stock has moved down by -13.3%

About Actuate Therapeutics

Actuate Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). The Company is developing elraglusib, a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3b, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, which lead to tumor cell survival, growth, migration, and invasion. Its candidate products are Elraglusib Injection and Elraglusib Oral Tablet. Elraglusib is the lead drug in the portfolio and is being evaluated in a randomized Phase II trial in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC). Elraglusib is designed to act as a mediator of antitumor immunity through the inhibition of NF-kB and regulates multiple immune checkpoints and immune cell function.

Organisation	Actuate Therapeutics
Headquarters	1751 River Run, Fort Worth, TX, United States, 76107
CEO	Mr. Daniel M. Schmitt
E-voting on shares	Click here to vote

Key Management of Actuate Therapeutics

Name	Title
Mr. Daniel M. Schmitt	CEO, President & Director
Dr. Andrew P. Mazar Ph.D.	Co-Founder & COO
Mr. Paul J. Lytle CPA	Chief Financial Officer
Dr. Alan Kozikowski Ph.D.	Scientific Founder and Advisor

FAQs

What is Actuate Therapeutics share price today?

Actuate Therapeutics share price today is $7.12 as on September 17, 2025 at 11:40 pm IST. Actuate Therapeutics share today touched a day high of $7.17 and a low of $6.92.

What is the 52 week high and 52 week low for Actuate Therapeutics share?

Actuate Therapeutics share touched a 52 week high of $11.99 on May 30, 2025 and a 52 week low of $5.47 on July 21, 2025. Actuate Therapeutics stock price today i.e. September 17, 2025 at 11:40 pm IST is trending at $7.12,which is 40.62% down from its 52 week high and 30.16% up from its 52 week low.

What is Actuate Therapeutics's market capitalisation today?

Actuate Therapeutics market capitalisation is $0.00T as on September 17, 2025 at 11:40 pm IST.

How to invest in Actuate Therapeutics Stock (ACTU) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Actuate Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Actuate Therapeutics Shares that will get you 0.2107 shares as per Actuate Therapeutics share price of $7.12 per share as on September 17, 2025 at 11:40 pm IST.

What is the minimum amount required to buy Actuate Therapeutics Stock (ACTU) from India?

Indian investors can start investing in Actuate Therapeutics (ACTU) shares with as little as ₹87.816 or $1 (as of September 17, 2025 at 11:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Actuate Therapeutics stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 11:41 pm IST). Based on Actuate Therapeutics share’s latest price of $7.12 as on September 17, 2025 at 11:40 pm IST, you will get 1.4045 shares of Actuate Therapeutics. Learn more about fractional shares .